Provided by Tiger Trade Technology Pte. Ltd.

Aurinia Pharmaceuticals

14.30
-0.0700-0.49%
Volume:199.39K
Turnover:2.85M
Market Cap:1.90B
PE:6.91
High:14.40
Open:14.13
Low:14.13
Close:14.37
52wk High:16.54
52wk Low:6.83
Shares:132.97M
Float Shares:128.06M
Volume Ratio:0.41
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.07
EPS(LYR):2.07
ROE:59.91%
ROA:11.16%
PB:3.27
PE(LYR):6.91

Loading ...

Aurinia Pharmaceuticals Raises 2025 Revenue and Net Product Sales Guidance

Reuters
·
Nov 04, 2025

Aurinia Pharmaceuticals Q3 EPS USD 0.23

THOMSON REUTERS
·
Nov 04, 2025

Aurinia Pharmaceuticals Inc - Lupkynis Sales Guidance Raised to $265-$270 Mln for 2025

THOMSON REUTERS
·
Nov 04, 2025

Aurinia Pharmaceuticals Inc - Diluted EPS up 130% in Q3 2025 to $0.23

THOMSON REUTERS
·
Nov 04, 2025

Aurinia Pharmaceuticals Q3 Pretax Profit USD 31.962 Million

THOMSON REUTERS
·
Nov 04, 2025

Aurinia Pharmaceuticals Outlook FY Revenue USD 275-280 Million

THOMSON REUTERS
·
Nov 04, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress

THOMSON REUTERS
·
Nov 04, 2025

STEP Energy Services Sends Circular for Shareholder Vote on Proposed Acquisition

Reuters
·
Nov 04, 2025

US FDA's drug division chief resigns amid ethics concerns and lawsuit

Reuters
·
Nov 04, 2025

Aurinia Pharmaceuticals Reportedly Files Lawsuit Against US FDA Official

MT Newswires Live
·
Nov 04, 2025

Aurinia Pharmaceuticals Inc expected to post earnings of 16 cents a share - Earnings Preview

Reuters
·
Nov 03, 2025

FDA official resigns, sued by Aurinia Pharmaceuticals, WSJ reports

TIPRANKS
·
Nov 03, 2025

Aurinia Pharmaceuticals Inc. to Report Q3 and Nine-Month 2025 Financial Results

Reuters
·
Nov 03, 2025

Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025

THOMSON REUTERS
·
Nov 03, 2025

Stocks to Watch Monday: Berkshire Hathaway, Onsemi, Palantir -- WSJ

Dow Jones
·
Nov 03, 2025

PRESS DIGEST -Wall Street Journal - November 3

Reuters
·
Nov 03, 2025

FDA Official Steps Down, Sued By Drugmaker -- WSJ

Dow Jones
·
Nov 03, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Oct 30, 2025

Aurinia Pharmaceuticals (AUPH): Evaluating Valuation as LUPKYNIS Momentum and Pipeline Updates Boost Growth Narrative

Simply Wall St.
·
Oct 27, 2025

Sasquatch Resources Acquires 14 Mineral Claims on Mount Sicker

Reuters
·
Oct 21, 2025